Adar Zinger, MD, PhD

University of Chicago Medicine, Inflammatory Bowel Disease Center

Poster(s):

• P3532 - Effectiveness and Safety of Risankizumab Induction Therapy in Crohn’s Disease: Prospective Real-World Experience in a Large Tertiary Center
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT